Stocktoria
PHIBRO ANIMAL HEALTH CORP PAHC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-04-11
PHIBRO ANIMAL HEALTH CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.0B | $977.9M | $942.3M | $833.4M |
| Gross profit | $399.9M | $313.1M | $298.2M | $285.4M | $271.4M |
| R&D expense | $23.7M | $29.2M | $24.4M | $20.8M | $17.8M |
| SG&A expense | $289.5M | $259.8M | $226.4M | $206.4M | $196.5M |
| Operating income | $110.5M | $53.3M | $71.8M | $79.0M | $74.9M |
| Interest expense | — | — | $18.7M | $12.7M | $13.7M |
| Income tax | $19.7M | $8.5M | $21.5M | $23.2M | $12.1M |
| Net income | $48.3M | $2.4M | $32.6M | $49.2M | $54.4M |
| EPS (diluted) | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 |
| Operating cash flow | $80.1M | $87.6M | $13.3M | $31.6M | $48.3M |
| Cash & equivalents | $68.0M | $70.6M | $41.3M | $74.2M | $50.2M |
| Inventory | $444.4M | $265.9M | $277.6M | $259.2M | $216.3M |
| Total assets | $1.4B | $982.2M | $971.4M | $931.7M | $841.3M |
| Total liabilities | $1.1B | $725.5M | $688.9M | $669.3M | $602.8M |
| Shareholders' equity | $285.7M | $256.6M | $282.5M | $262.4M | $238.5M |
Source: SEC EDGAR filings · CIK 0001069899 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.